Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company JB Therapeutics Inc.
DescriptionCB1 and CB2 agonist
Molecular Target Cannabinoid CB1 receptor (CNR1) ; Cannabinoid CB2 receptor (CNR2)
Mechanism of ActionCannabinoid CB2 receptor agonist; Cannabinoid CB1 receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat chronic refractory neuropathic pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today